New Job Cuts at Pfizer?
.jpg)
The new CEO at Pfizer is contemplating new job cuts that may affect thousands of employees. Also, sources close to the situation indicated that Pfizer will overhaul its drug discovery and development program so that the company can more efficiently discover and develop new products. These changes were not unexpected after the former CEO Hank McKinell ran the company into the ground and was rewarded with a severance package of over $200 million. Late last year Pfizer laid off hundreds of its sales representative to consolidate its sales force and cut costs. For you business minded folks out there, Pfizer is a case study in a company that expanded too quickly without a strategic vison or plan. As I have noted previously, "bigger is not always better" in some situations.
Until next time....
Good Luck and Good Job Hunting!!!!!!!!!!!
I have a biotech company whose technology targets ischemia induced oxidative stress which underlies conditions such as heart failure, angina, acute coronary syndrome, myocardial infarction, diabetes type 2, peripheral arterial disease and stroke. It involves a proprietary combination of a statin and a metabolic modulating agent that can be administered as a single time release tablet twice daily to all patients regardless of their blood pressure, heart rate or the presence of asthma-like lung diseases.
This technology is is partially described in PCT/US2006/008801 on the USPTO website.I would be interested in discussing the clinical development pathway with any potential investors. My phone is 706-267-8878.
W H Kaesemeyer MD
CEO
HKNO,Ltd.